AAAAAA

   
Results: 1-19 |
Results: 19
HEMORRHAGIC COMPLICATIONS OF ANTICOAGULANT TREATMENT
Authors: LEVINE MN RASKOB G LANDEFELD S KEARON C
Citation: Mn. Levine et al., HEMORRHAGIC COMPLICATIONS OF ANTICOAGULANT TREATMENT, Chest, 114(5), 1998, pp. 511-523
OPINIONS REGARDING THE DIAGNOSIS AND MANAGEMENT OF VENOUS THROMBOEMBOLIC DISEASE
Authors: STEIN PD GOLDHABER SZ GOTTSCHALK A HULL RD HYERS TM LEEPER KV MOSER KM PINEO GF RASKOB G SALTZMAN HA SOSTMAN D TAPSON VF WEG JG
Citation: Pd. Stein et al., OPINIONS REGARDING THE DIAGNOSIS AND MANAGEMENT OF VENOUS THROMBOEMBOLIC DISEASE, Chest, 113(2), 1998, pp. 499-504
INCIDENCE OF DEEP-VEIN THROMBOSIS AFTER ARTHROSCOPIC KNEE SURGERY
Authors: DURICA S RASKOB G JOHNSON C JANSSEN T JAY G HARGROVE K COMP P BIRDWELL B HULL R
Citation: S. Durica et al., INCIDENCE OF DEEP-VEIN THROMBOSIS AFTER ARTHROSCOPIC KNEE SURGERY, Thrombosis and haemostasis, 1997, pp. 741-741
RELATION BETWEEN THE TIME TO ACHIEVE THE TOWER LIMIT OF THE APTT THERAPEUTIC RANGE AND RECURRENT VENOUS THROMBOEMBOLISM DURING HEPARIN TREATMENT FOR DEEP-VEIN THROMBOSIS
Authors: RASKOB G HULL R PINEO G VALENTINE K BRANT R
Citation: G. Raskob et al., RELATION BETWEEN THE TIME TO ACHIEVE THE TOWER LIMIT OF THE APTT THERAPEUTIC RANGE AND RECURRENT VENOUS THROMBOEMBOLISM DURING HEPARIN TREATMENT FOR DEEP-VEIN THROMBOSIS, Thrombosis and haemostasis, 1997, pp. 1580-1580
CLINICAL VALIDITY OF NORMAL COMPRESSION ULTRASOUND FOR SUSPECTED DEEP-VEIN THROMBOSIS IN OUTPATIENTS
Authors: BIRDWELL B RASKOB G WHITSETT T DURICA S COMP P GEORGE J TYTLE T MCKEE P
Citation: B. Birdwell et al., CLINICAL VALIDITY OF NORMAL COMPRESSION ULTRASOUND FOR SUSPECTED DEEP-VEIN THROMBOSIS IN OUTPATIENTS, Thrombosis and haemostasis, 1997, pp. 2402-2402
THE USE OF A NOMOGRAM TO CONTROL WARFARIN THERAPY - INR DATA
Authors: PINEO GF HULL RD BRANT R RASKOB G ROSENBLOOM D
Citation: Gf. Pineo et al., THE USE OF A NOMOGRAM TO CONTROL WARFARIN THERAPY - INR DATA, Thrombosis and haemostasis, 1997, pp. 2854-2854
ACUTE IDIOPATHIC THROMBOCYTOPENIC PURPURA - MANAGEMENT IN CHILDHOOD -RESPONSE
Authors: GEORGE JN WOOLF SH RASKOB G WASSER JS ALEDORT LM BALLEM PJ BLANCHETTE VS BUSSEL JB CINES DB KELTON JG LICHTIN AE MCMILLAN R OKERBLOOM JA REGAN DH WARRIER I
Citation: Jn. George et al., ACUTE IDIOPATHIC THROMBOCYTOPENIC PURPURA - MANAGEMENT IN CHILDHOOD -RESPONSE, Blood, 89(4), 1997, pp. 1466-1466
OPINIONS REGARDING THE DIAGNOSIS AND MANAGEMENT OF VENOUS THROMBOEMBOLIC DISEASE
Authors: STEIN PD DALEN JE GOLDHABER SZ GOTTSCHALK A HULL RD LEEPER KV MOSER KM RASKOB G SALTZMAN HA SOSTMAN HD TAPSON VF WEG JG
Citation: Pd. Stein et al., OPINIONS REGARDING THE DIAGNOSIS AND MANAGEMENT OF VENOUS THROMBOEMBOLIC DISEASE, Chest, 109(1), 1996, pp. 233-237
LOW-DOSE WARFARIN-ASPIRIN - EFFECT ON ACTIVATED FACTOR-VII
Authors: RASKOB G DURICA S MORRISSEY J OWEN W COMP P
Citation: G. Raskob et al., LOW-DOSE WARFARIN-ASPIRIN - EFFECT ON ACTIVATED FACTOR-VII, The FASEB journal, 9(4), 1995, pp. 939-939
HEMORRHAGIC COMPLICATIONS OF ANTICOAGULANT TREATMENT
Authors: LEVINE MN RASKOB G LANDEFELD S HIRSH J
Citation: Mn. Levine et al., HEMORRHAGIC COMPLICATIONS OF ANTICOAGULANT TREATMENT, Chest, 108(4), 1995, pp. 276-290
RISKS FOR BLEEDING IN PATIENTS WITH PULMONARY-EMBOLISM TREATED WITH THROMBOLYTIC AGENTS - RESPONSE
Authors: STEIN PD HULL RD RASKOB G
Citation: Pd. Stein et al., RISKS FOR BLEEDING IN PATIENTS WITH PULMONARY-EMBOLISM TREATED WITH THROMBOLYTIC AGENTS - RESPONSE, Annals of internal medicine, 122(8), 1995, pp. 631-632
A STANDARDIZED PRESCRIPTIVE WARFARIN SODIUM NOMOGRAM
Authors: HULL R RASKOB G PINEO G BRANT R
Citation: R. Hull et al., A STANDARDIZED PRESCRIPTIVE WARFARIN SODIUM NOMOGRAM, Clinical research, 42(2), 1994, pp. 10000185-10000185
AGE-GENDER EFFECT ON HEPARIN LEVELS DURING THERAPY
Authors: CAMPBELL NRC HULL R BRANT R HOGAN D RASKOB G PINEO G
Citation: Nrc. Campbell et al., AGE-GENDER EFFECT ON HEPARIN LEVELS DURING THERAPY, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 172-172
THE EFFECT OF AGE AND GENDER ON APTT RESPONSE TO HEPARIN
Authors: CAMPBELL NRC HULL R BRANT R HOGAN D RASKOB G PINEO G
Citation: Nrc. Campbell et al., THE EFFECT OF AGE AND GENDER ON APTT RESPONSE TO HEPARIN, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 172-172
SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) VERSUS WARFARIN SODIUM (WS) FOR PROPHYLAXIS OF DEEP-VEIN THROMBOSIS (DVT) AFTER TOTAL HIP OR TOTAL KNEE REPLACEMENT (THR TKR) - AN ECONOMIC-PERSPECTIVE/
Authors: HULL RD RASKOB G PINEO GF FELDSTEIN W ROSENBLOOM D GAFNI A GREEN D FEINGLASS J TROWBRIDGE A ELLIOTT G LERNER R BRANT R
Citation: Rd. Hull et al., SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN (LMWH) VERSUS WARFARIN SODIUM (WS) FOR PROPHYLAXIS OF DEEP-VEIN THROMBOSIS (DVT) AFTER TOTAL HIP OR TOTAL KNEE REPLACEMENT (THR TKR) - AN ECONOMIC-PERSPECTIVE/, Blood, 84(10), 1994, pp. 10000070-10000070
RISKS FOR MAJOR BLEEDING FROM THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE PULMONARY-EMBOLISM - CONSIDERATION OF NONINVASIVE MANAGEMENT
Authors: STEIN PD HULL RD RASKOB G
Citation: Pd. Stein et al., RISKS FOR MAJOR BLEEDING FROM THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE PULMONARY-EMBOLISM - CONSIDERATION OF NONINVASIVE MANAGEMENT, Annals of internal medicine, 121(5), 1994, pp. 313-317
A COMPARISON OF SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN WITH WARFARIN SODIUM FOR PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER HIP OR KNEE IMPLANTATION
Authors: HULL R RASKOB G PINEO G ROSENBLOOM D EVANS W MALLORY T ANQUIST K SMITH F HUGHES G GREEN D ELLIOTT CG PANJU A BRANT R
Citation: R. Hull et al., A COMPARISON OF SUBCUTANEOUS LOW-MOLECULAR-WEIGHT HEPARIN WITH WARFARIN SODIUM FOR PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER HIP OR KNEE IMPLANTATION, The New England journal of medicine, 329(19), 1993, pp. 1370-1376
SAFETY AND EFFICACY OF A LOW-DOSE COMBINATION OF COUMADIN AND ASPIRIN
Authors: LANGER A GOODMAN SG COMP PC RASKOB G DURICA S GRAY RJ HALL J KELLEY RP HUA IA LEE RJ
Citation: A. Langer et al., SAFETY AND EFFICACY OF A LOW-DOSE COMBINATION OF COUMADIN AND ASPIRIN, Circulation, 88(4), 1993, pp. 493-493
HEPARIN (H) RESISTANCE AS A PREDICTOR OF RECURRENT VENOUS THROMBOEMBOLISM (RVTE)
Authors: HULL R BRANT R PINEO G RASKOB G ROSENBLOOM D
Citation: R. Hull et al., HEPARIN (H) RESISTANCE AS A PREDICTOR OF RECURRENT VENOUS THROMBOEMBOLISM (RVTE), Blood, 82(10), 1993, pp. 10000407-10000407
Risultati: 1-19 |